{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:58:51Z","timestamp":1791104331909,"version":"4.1.0"},"reference-count":352,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.nbd.2011.10.019","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T13:19:00Z","timestamp":1319807940000},"page":"508-526","source":"Crossref","is-referenced-by-count":79,"title":["Neurochemistry and the non-motor aspects of PD"],"prefix":"10.1016","volume":"46","author":[{"given":"I.","family":"Ferrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"L\u00f3pez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dalf\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2011.10.019_bb0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrn1868","article-title":"Expanding insights of mitochondrial dysfunction in Parkinson's disease","volume":"7","author":"Abou-Sleiman","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2011.10.019_bb0010","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1471-4159.1997.69031326.x","article-title":"A generalized increase in protein carbonyls in the brain in Parkinson's disease but not in incidental Lewy body disease","volume":"69","author":"Alam","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.10.019_bb0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1212\/WNL.0b013e31820882aa","article-title":"Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study","volume":"76","author":"Alcalay","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb1760","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","article-title":"Chaperone-mediated autophagy markers in Parkinson disease brains","volume":"67","author":"Alvarez-Erviti","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0025","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser 129 is the dominant pathological modification of synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.10.019_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-8993(99)01848-X","article-title":"Cellular co-localization of phosphorylated tau- and NACP\/alpha-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies","volume":"843","author":"Arima","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.10.019_bb0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.21912","article-title":"Sleep induced by stimulation in the human pedunculopontine nucleus area","volume":"67","author":"Arnulf","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.clineuro.2008.11.007","article-title":"Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease","volume":"111","author":"Asai","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.nbd.2011.10.019_bb0045","first-page":"879","article-title":"Aggregation of \u03b1-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0050","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/mds.23602","article-title":"Association of olfactory dysfunction and brain. Metrabolism in Parkinson's disease","volume":"26","author":"Baba","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jns.2006.05.006","article-title":"Morphological alterations of the synapses in the locus coeruleus in Parkinson's disease","volume":"248","author":"Baloyannis","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nbd.2005.11.005","article-title":"Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies","volume":"22","author":"Barrachina","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.10.019_bb1765","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1002\/pmic.200400848","article-title":"Proteome analysis of human substantia nigra in Parkinson's disease","volume":"4","author":"Basso","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.nbd.2011.10.019_bb1770","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Arizona Parkinson's disease Consortium. Multi-organ distribution of phosphorylated \u03b1-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0075","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/brain\/awh376","article-title":"Involvement of medullary regions controlling sympathetic output in Lewy body disease","volume":"128","author":"Benarroch","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF01663632","article-title":"Responsibility of extrastriatal areas for the appearance of psychotic symptoms (clinical and biochemical human post-mortem findings)","volume":"37","author":"Birkmayer","year":"1975","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.10.019_bb0090","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2990.2006.00727.x","article-title":"Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects","volume":"32","author":"Bloch","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2009.05115.x","article-title":"REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions","volume":"1184","author":"Boeve","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb0095","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1212\/WNL.0b013e3181b0bd3d","article-title":"Cholinergic denervation occurs early in Parkinson disease","volume":"73","author":"Bohnen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb0100","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbr.2009.12.048","article-title":"The cholinergic system and Parkinson disease","volume":"221","author":"Bohnen","year":"2011","journal-title":"Behav. Brain Res. J. Behav. Brain Res."},{"key":"10.1016\/j.nbd.2011.10.019_bb0110","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/brain\/awq079","article-title":"Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease","volume":"133","author":"Bohnen","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb0105","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2967\/jnumed.111.089946","article-title":"Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study","volume":"52","author":"Bohnen","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nbd.2011.10.019_bb0115","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"issue":"Suppl 65","key":"10.1016\/j.nbd.2011.10.019_bb1775","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-7091-0643-3_11","article-title":"The role of acetylcholine and dopamine in dementia and psychosis in Parkinson's disease","author":"Bosboom","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.10.019_bb0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1750-3639.2008.00171.x","article-title":"Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death","volume":"19","author":"Bossers","year":"2009","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1780","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.biophys.28.1.295","article-title":"The proteasome","volume":"28","author":"Botchler","year":"1999","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.nbd.2011.10.019_bb0135","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neurobiolaging.2007.02.002","article-title":"Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disaese","volume":"29","author":"Bouchard","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.10.019_bb0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.expneurol.2008.04.001","article-title":"Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered","volume":"212","author":"Braak","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3940(99)00208-6","article-title":"Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry","volume":"265","author":"Braak","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"suppl 3","key":"10.1016\/j.nbd.2011.10.019_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-002-1301-4","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)","volume":"249","author":"Braak","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1785","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.10.019_bb0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.nbd.2011.10.019_bb1790","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","article-title":"Cognitive status correlates with neuropathologic state in Parkinson disease","volume":"64","author":"Braak","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.10.019_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-211-45295-0_15","article-title":"Pathology associated with sporadic Parkinson's disease: where does it end?","volume":"70","author":"Braak","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.nbd.2011.10.019_bb0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","article-title":"Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease","volume":"114","author":"Braak","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0079-6123(10)84011-7","article-title":"Imaging non-motor aspects of Parkinson's disease","volume":"184","author":"Brooks","year":"2010","journal-title":"Progr. Brain Res."},{"key":"10.1016\/j.nbd.2011.10.019_bb0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.21541","article-title":"A critical evaluation of the Braak staging scheme for Parkinson's disease","volume":"64","author":"Burke","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0195","series-title":"Redox Proteomics: From Protein Modifications to Cellular Dysfunction and Diseases","first-page":"399","article-title":"Oxidative damage to proteins: structural modifications and consequences in cell function","author":"Cabiscol","year":"2006"},{"key":"10.1016\/j.nbd.2011.10.019_bb0205","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1474-4422(06)70600-7","article-title":"A convergent model of cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance","volume":"5","author":"Calabresi","year":"2006","journal-title":"Lancet Neurol."},{"issue":"Suppl 3","key":"10.1016\/j.nbd.2011.10.019_bb0200","doi-asserted-by":"crossref","first-page":"S259","DOI":"10.1016\/S1353-8020(08)70013-0","article-title":"Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits","volume":"13","author":"Calabresi","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0210","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nbd.2007.02.009","article-title":"Effects of gender on nigral gene expression and Parkinson disease","volume":"26","author":"Cantuti-Castelvetri","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.10.019_bb0215","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1586\/ern.10.54","article-title":"Using \u2018omics\u2019 to define pathogenesis and biomarkers of Parkinson disease","volume":"10","author":"Caudle","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.nbd.2011.10.019_bb0220","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.nbd.2011.10.019_bb1795","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11910-005-0072-6","article-title":"The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential","volume":"205","author":"Chaudhuri","year":"2005","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.nbd.2011.10.019_bb0230","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nbd.2008.11.011","article-title":"Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease","volume":"33","author":"Chen","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.10.019_bb0235","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/pr070546l","article-title":"Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analysis of striata in two mouse models of Parkinson's disease","volume":"7","author":"Chin","year":"2008","journal-title":"J. Proteom. Res."},{"key":"10.1016\/j.nbd.2011.10.019_bb0240","doi-asserted-by":"crossref","first-page":"13256","DOI":"10.1074\/jbc.M314124200","article-title":"Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's disease","volume":"279","author":"Choi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.10.019_bb0245","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1074\/jbc.M414327200","article-title":"Oxidative modifications and aggregation of Cu, Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases","volume":"280","author":"Choi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.10.019_bb0250","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.1074\/jbc.M509079200","article-title":"Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases","volume":"281","author":"Choi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.10.019_bb0255","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5483\/BMBRep.2010.43.4.225","article-title":"The role of neuroinflammation on the pathogenesis of Parkinson's disease","volume":"43","author":"Chung","year":"2010","journal-title":"BMB Rep."},{"key":"10.1016\/j.nbd.2011.10.019_bb0260","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00011-009-0026-6","article-title":"The impact of age and gender on the striatal astrocytes activation in murine model of Parkinson's disease","volume":"58","author":"Ciesielska","year":"2009","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.nbd.2011.10.019_bb0275","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1212\/WNL.0b013e3181ec7fac","article-title":"REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century","volume":"75","author":"Claassen","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb0265","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/NEN.0b013e3181927577","article-title":"Early-onset familial Lewy body dementia: a clinical, genetic and neuropathological study","volume":"68","author":"Clarim\u00f3n","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0270","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.10.019_bb0280","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1093\/brain\/awp263","article-title":"Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia","volume":"132","author":"Compta","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb0285","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/brain\/awf052","article-title":"Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET","volume":"125","author":"Cools","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb1800","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00702-010-0397-4","article-title":"Parkinson's disease-associated DJ-1 modulates innate immunity signaling in Caenorhabditis elegans","volume":"117","author":"Cornejo Castro","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.10.019_bb1805","series-title":"Handbook of Proteins. Structure, Function and Methods","author":"Cox","year":"2007"},{"key":"10.1016\/j.nbd.2011.10.019_bb0300","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/pmic.200700728","article-title":"Assessing quantitative post-mortem changes in the gray matter of the human frontal cortex proteome by 2-D DIGE","volume":"8","author":"Crecelius","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.nbd.2011.10.019_bb0305","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pscychresns.2007.11.003","article-title":"Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C] NNC112 and [18F] FDOPA","volume":"163","author":"Cropley","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.nbd.2011.10.019_bb0310","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2001-13116","article-title":"Functional neuroimaging in Parkinson's disease","volume":"21","author":"Dagher","year":"2001","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0325","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neurobiolaging.2006.10.022","article-title":"Early \u03b1-synuclein lipoxidation in neocortex in Lewy body diseases","volume":"29","author":"Dalf\u00f3","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.10.019_bb0315","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1750-3639.2004.tb00082.x","article-title":"Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein\/phospholipase C (PLCbeta1) interactions","volume":"14","author":"Dalf\u00f3","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0320","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nbd.2004.01.001","article-title":"Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease","volume":"16","author":"Dalf\u00f3","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.10.019_bb1810","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jnen\/63.4.302","article-title":"Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice","volume":"63","author":"Dalf\u00f3","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nbd.2011.10.019_bb0335","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.jnen.0000179050.54522.5a","article-title":"Evidence of oxidative stress in the neocortex in incidental Lewy body disease","volume":"64","author":"Dalf\u00f3","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0340","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0140-6736(92)93275-R","article-title":"Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology","volume":"340","author":"Daniel","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2011.10.019_bb0345","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","article-title":"Where does Parkinson disease pathology begin in the brain?","volume":"61","author":"Del Tredici","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0355","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/JCP.0b013e3181bf1c5f","article-title":"Dopaminergic modulation of amygdala activity during emotion recognition in patients with Parkinson disease","volume":"29","author":"Delaveau","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0350","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archneur.65.8.1074","article-title":"Incidental Lewy body disease and preclinical Parkinson disease","volume":"65","author":"DelleDonne","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0360","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00019052-200108000-00001","article-title":"Alpha-synuclein and the Lewy body disorders","volume":"14","author":"Dickson","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0375","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","article-title":"Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease","volume":"115","author":"Dickson","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0365","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"issue":"Suppl 3","key":"10.1016\/j.nbd.2011.10.019_bb0370","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1353-8020(09)70769-2","article-title":"Neuropathology of non-motor features of Parkinson disease","volume":"15","author":"Dickson","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Suppl 1","key":"10.1016\/j.nbd.2011.10.019_bb0380","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1002\/mds.22637","article-title":"Evidence in favor of Braak staging of Parkinson's disease","volume":"25","author":"Dickson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0390","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neuroimage.2004.11.023","article-title":"Executive dysfunction in Parkinson's disease is associated with altered pallidal-frontal processing","volume":"25","author":"Dirnberger","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbd.2011.10.019_bb0395","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.conb.2007.04.010","article-title":"Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease","volume":"17","author":"Dodson","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1815","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/mds.20263","article-title":"Hallucinations in Parkinson's disease: a follow-up study","volume":"20","author":"Doe De Maindreville","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0405","doi-asserted-by":"crossref","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","article-title":"Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153","volume":"285","author":"Doxakis","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.10.019_bb0410","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.410280202","article-title":"Cholinergic deficiency and frontal dysfunction in Parkinson's disease","volume":"28","author":"Dubois","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0415","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0002-9440(10)64781-5","article-title":"Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies","volume":"157","author":"Duda","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0385","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-002-0563-3","article-title":"Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred","volume":"104","author":"Duda","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0420","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10048-006-0033-5","article-title":"Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease","volume":"7","author":"Duke","year":"2006","journal-title":"Neurogenetics"},{"key":"10.1016\/j.nbd.2011.10.019_bb1820","doi-asserted-by":"crossref","DOI":"10.2119\/molmed.2011.00119","article-title":"Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease","author":"Fabelo","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.nbd.2011.10.019_bb0430","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14789450.5.2.239","article-title":"Alpha-synuclein and Parkinson disease: a proteomic view","volume":"5","author":"Fasano","year":"2008","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.nbd.2011.10.019_bb0435","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2009.02.004","article-title":"Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects","volume":"88","author":"Ferrer","year":"2009","journal-title":"Progr. Neurobiol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0440","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10863-009-9243-5","article-title":"Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease","volume":"41","author":"Ferrer","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.nbd.2011.10.019_bb1825","first-page":"708404","article-title":"Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease","author":"Ferrer","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.nbd.2011.10.019_bb0465","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neulet.2007.01.026","article-title":"Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease","volume":"415","author":"Ferrer","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.10.019_bb0450","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1750-3639.2010.00390.x","article-title":"General aspects and neuropathology of X-linked adrenoleukodystrophy","volume":"20","author":"Ferrer","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0455","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2010-101485","article-title":"Neuronal hemoglobin is reduced in Alzheimer's disease, argyrophilic grain disease, Parkinson's disease, and dementia with Lewy bodies","volume":"23","author":"Ferrer","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2011.10.019_bb0460","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00702-010-0482-8","article-title":"Neuropathology of sporadic Parkinson disease (PD) before the appearance of parkinsonism: incidental PD","volume":"118","author":"Ferrer","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.10.019_bb0470","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0475","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/hmg\/ddn085","article-title":"Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy","volume":"1","author":"Fourcade","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.10.019_bb0480","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neurobiolaging.2009.05.019","article-title":"Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?","volume":"32","author":"Frigerio","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.10.019_bb0485","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.parkreldis.2008.04.038","article-title":"The neuropathological basis for depression in Parkinson's disease","volume":"15","author":"Frisina","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0490","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/brain\/awm090","article-title":"Hypocretin (orexin) loss in Parkinson's disease","volume":"130","author":"Fronczek","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb0495","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mds.21989","article-title":"Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease","volume":"23","author":"Fujishiro","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0500","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00401-008-0383-1","article-title":"Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies","volume":"116","author":"Fujishiro","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0505","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"\u03b1-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1830","first-page":"21453200","article-title":"Oxidative damage compromises energy metasbolism in the axonal degeneration mouse model of X-adrenoleukodystrphy","author":"Galino","year":"2011","journal-title":"Antiox. Redox. Signal"},{"key":"10.1016\/j.nbd.2011.10.019_bb0520","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","article-title":"Synucleinopathies: clinical and pathological implications","volume":"58","author":"Galvin","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0525","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1017\/S1462399409001148","article-title":"Molecular pathogenesis of Parkinson disease: insights from genetic studies","volume":"11","author":"Gasser","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.nbd.2011.10.019_bb0530","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-009-0596-y","article-title":"Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson's disease: an anatomical study","volume":"118","author":"Ghebremedhin","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0535","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective \u03b1-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.10.019_bb0540","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin\u2013proteasome proteolytic pathway: destruction for the sake of construction","volume":"82","author":"Glickman and Ciechanover","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2011.10.019_bb0545","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1515\/CCLM.2001.047","article-title":"Parkinson's disease and other \u03b1-synucleinopathies","volume":"39","author":"Goedert","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.nbd.2011.10.019_bb0550","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/WNL.0b013e3181fd6158","article-title":"Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study","volume":"75","author":"Goetz","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb0555","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1212\/01.wnl.0000230215.41296.18","article-title":"Glucocerebrosidase mutations are an important risk factor for Lewy body disorders","volume":"67","author":"Goker-Alpan","year":"2006","journal-title":"Neurology"},{"issue":"74","key":"10.1016\/j.nbd.2011.10.019_bb1835","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1212\/WNL.0b013e3181ca014c","article-title":"Association of anosmia with autonomic failure in Parkinson disease","volume":"10","author":"Goldstein","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb1840","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2011.04.011","article-title":"Autonomic dysfunction in PD: a window to early detection?","author":"Goldstein","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb0575","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-010-0669-y","article-title":"Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment","volume":"20","author":"Gomez","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0570","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/jnr.21904","article-title":"Increased oxidation of certain glycolysis and energy metabolism enzymes in the frontal cortex in Lewy body diseases","volume":"87","author":"G\u00f3mez","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.10.019_bb0580","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00702-004-0212-1","article-title":"Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin\u2013proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion\/cellular matrix and vesicle trafficking genes","volume":"111","author":"Grundblatt","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.10.019_bb0585","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-6606-3-12","article-title":"Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice","volume":"3","author":"Gu","year":"2010","journal-title":"Mol. Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb1845","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s004010050693","article-title":"The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature","volume":"94","author":"Hague","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0605","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mds.23455","article-title":"Glia: initiators and progressors of pathology in Parkinson's disease","volume":"26","author":"Halliday","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0600","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","article-title":"The progression of pathology in longitudinally followed patients with Parkinson's disease","volume":"115","author":"Halliday","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0590","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using \u03b1-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0610","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awf033","article-title":"Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb0615","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.gde.2009.03.008","article-title":"The genetics of Parkinson's syndromes: a critical review","volume":"19","author":"Hardy","year":"2009","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.nbd.2011.10.019_bb0620","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1750-3639.1999.tb00552.x","article-title":"\u03b1-Synuclein in Lewy body disease and Alzheimer's disease","volume":"9","author":"Hashimoto","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0625","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1023\/A:1026073324672","article-title":"Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies","volume":"28","author":"Hashimoto","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2011.10.019_bb0630","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1093\/brain\/awp293","article-title":"Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease","volume":"132","author":"Hattingen","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb0635","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archneur.62.6.917","article-title":"Expression profiling of substantia nigra in Parkinson's disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism","volume":"62","author":"Hauser","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0640","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"International LRRK2 Consortium. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case\u2013control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0645","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Herschko","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.nbd.2011.10.019_bb0650","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00415-008-0665-5","article-title":"A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease","volume":"255","author":"Herting","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0655","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","article-title":"Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways","volume":"65","author":"Hilker","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb0660","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0047-6374(02)00091-X","article-title":"A higher oxidative status accelerates senescence and aggravates age-dependent disorders in SAMP strains of mice","volume":"123","author":"Hosokawa","year":"2002","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.nbd.2011.10.019_bb0670","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/awm086","article-title":"Changes in network activity with the progression of Parkinson's disease","volume":"130","author":"Huang","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb0665","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1212\/01.wnl.0000304050.05332.9c","article-title":"Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease","volume":"70","author":"Huang","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb0675","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1469-7580.2007.00748.x","article-title":"\u03b1-Synuclein pathology in the olfactory pathways of dementia patients","volume":"211","author":"Hubbard","year":"2007","journal-title":"J. Anat."},{"key":"10.1016\/j.nbd.2011.10.019_bb0680","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jns.2009.08.026","article-title":"Immunohistochemical, volumetric, and functional neuroimaging studies in patients with idiopathic Parkinson's disease","volume":"289","author":"Hummel","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb0685","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","article-title":"Causal relation between \u03b1-synuclein gene duplication and familial Parkinson's disease","volume":"364","author":"Ibanez","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2011.10.019_bb0690","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1460-9568.2009.06892.x","article-title":"Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease","volume":"30","author":"Ibarretxe-Bilbao","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.10.019_bb0695","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/NEN.0b013e318186de48","article-title":"Lewy body pathology involves cutaneous nerves","volume":"67","author":"Ikemura","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1850","series-title":"Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders","first-page":"188","article-title":"Dementia with Lewy bodies","author":"Ince","year":"2003"},{"key":"10.1016\/j.nbd.2011.10.019_bb0705","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/jnnp.64.4.533","article-title":"Auditory hallucinations in Parkinson's disease","volume":"64","author":"Inzelberg","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.nbd.2011.10.019_bb1855","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2011.07.049","article-title":"Sleep\u2013wake changes in the premotor stage of Parkinson disease","author":"Iranzo","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb0715","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","article-title":"Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study","volume":"5","author":"Iranzo","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1860","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00005072-199804000-00005","article-title":"Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body diseases contain alpha-synuclein immunoreactivity","volume":"57","author":"Irizarry","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0725","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/01.jnen.0000195941.48033.eb","article-title":"Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase","volume":"65","author":"Ishida","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0730","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ana.20393","article-title":"A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease","volume":"57","author":"Ishikawa","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0735","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","article-title":"Colocalization of tau and alpha-synuclein epitopes in Lewy bodies","volume":"62","author":"Ishizawa","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0740","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1212\/WNL.52.6.1269","article-title":"Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body disease","volume":"52","author":"Iwanaga","year":"1999","journal-title":"Neurology"},{"issue":"suppl 3","key":"10.1016\/j.nbd.2011.10.019_bb0745","first-page":"11","article-title":"Aggregation of \u03b1-synuclein in the pathogenesis of Parkinson's disease","volume":"250","author":"Iwatsubo","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0750","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.parkreldis.2010.08.022","article-title":"Multi-organ autonomic dysfunction in Parkinson disease","volume":"17","author":"Jain","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0755","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00702-004-0138-7","article-title":"Lewy body-related synucleinopathy in the aged human brain","volume":"111","author":"Jellinger","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.10.019_bb0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","article-title":"A critical reappraisal of current staging of Lewy-related pathology in human brain","volume":"116","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0765","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","article-title":"A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders","volume":"1792","author":"Jellinger","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2011.10.019_bb0770","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000285518","article-title":"Prevalence and impact of cerebrovascular lesions in Alzheimer and Lewy body diseases","volume":"7","author":"Jellinger","year":"2010","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.nbd.2011.10.019_bb0775","series-title":"Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders","first-page":"159","article-title":"Parkinson's disease","author":"Jellinger","year":"2003"},{"key":"10.1016\/j.nbd.2011.10.019_bb0780","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1074\/mcp.M500382-MCP200","article-title":"Proteomic identification of a stress protein, mortalin\/mthsp70\/GRP75: relevance to Parkinson disease","volume":"5","author":"Jin","year":"2006","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.nbd.2011.10.019_bb0785","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.parkreldis.2010.08.021","article-title":"[(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia","volume":"16","author":"Jokinen","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0790","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","article-title":"Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains","volume":"30","author":"Jowaed","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.10.019_bb0795","doi-asserted-by":"crossref","first-page":"13052","DOI":"10.1073\/pnas.0906277106","article-title":"Repression of alpha-synuclein expression and toxicity by microRNA-7","volume":"106","author":"Junn","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.10.019_bb0800","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/mds.22897","article-title":"Nonmotor symptoms in Parkin gene-related parkinsonism","volume":"25","author":"K\u00e4gi","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0805","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.parkreldis.2008.05.007","article-title":"Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease","volume":"15","author":"Kalaitzakis","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0810","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0010-9452(08)70026-1","article-title":"Recognition of emotion from facial, prosodic and written verbal stimuli in Parkinson's disease","volume":"38","author":"Kan","year":"2002","journal-title":"Cortex"},{"key":"10.1016\/j.nbd.2011.10.019_bb1865","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3174\/ajnr.A0850","article-title":"Altered diffusion in the frontal lobe in Parkinson disease","volume":"29","author":"Karagulle Kendi","year":"2008","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0820","first-page":"1099","article-title":"Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies","volume":"47","author":"Kashihara","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nbd.2011.10.019_bb0825","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1523\/JNEUROSCI.0984-06.2006","article-title":"Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled","volume":"26","author":"Keeney","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.10.019_bb0830","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.10.019_bb0835","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/prca.200800028","article-title":"Identification of proteins in human substantia nigra","volume":"2","author":"Kitsou","year":"2008","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.nbd.2011.10.019_bb0840","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1212\/WNL.0b013e3181d55f61","article-title":"Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo","volume":"74","author":"Klein","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb9000","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00314594","article-title":"Diffuse Lewy body disease in Japan","volume":"237","author":"Kosaka","year":"1990","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0845","first-page":"456","article-title":"Dementia and neuropathology in Lewy body disease","volume":"60","author":"Kosaka","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0850","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2004.01.007","article-title":"Fibrillization of \u03b1-synuclein and tau in familial Parkinson's disease caused by the A53T \u03b1-synuclein mutation","volume":"187","author":"Kotzbauer","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0855","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00401-003-0705-2","article-title":"Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease","volume":"106","author":"K\u00f6vari","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0860","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding \u03b1-synuclein in Parkinson's disease","volume":"18","author":"Kr\u00fcger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.10.019_bb1870","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/mds.22246","article-title":"Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia","volume":"23","author":"Kulisevsky","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0870","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mds.23609","article-title":"A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials","volume":"26","author":"Lang","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0875","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.10.019_bb0880","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/WAD.0b013e3181d71a13","article-title":"Influence of white matter hyperintensities on the cognition of patients with Parkinson disease","volume":"24","author":"Lee","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0885","first-page":"987084","article-title":"Effects of human alpha-synuclein A53T-A30P mutations on SVZ and local olfactory bulb cell proliferation in a transgenic rat model of Parkinson disease","volume":"2011","author":"Lelan","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.nbd.2011.10.019_bb0890","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson's disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.10.019_bb0895","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1371\/journal.pgen.0030098","article-title":"A genomic pathway approach to a complex disease: axon guidance and Parkinson disease","volume":"3","author":"Lesnick","year":"2007","journal-title":"PLoS Gen"},{"key":"10.1016\/j.nbd.2011.10.019_bb0900","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1750-3639.2007.00048.x","article-title":"Proteomic identification of novel proteins in cortical Lewy bodies","volume":"17","author":"Leverenz","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0905","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.parkreldis.2009.02.003","article-title":"Parkinson's disease dementia: a diminished role for the Lewy body","volume":"15","author":"Libow","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0910","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1586\/14789450.4.6.769","article-title":"Ubiquitin\u2013proteasome system dysfunction in Parkinson's disease: current evidence and controversies","volume":"4","author":"Lim","year":"2007","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.nbd.2011.10.019_bb0915","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archneurol.2008.561","article-title":"Overview of the extranigral aspects of Parkinson disease","volume":"66","author":"Lim","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0920","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4","article-title":"Antibodies to \u03b1-synuclein detect Lewy bodies in many Down's syndrome brains with Azheimer's disease","volume":"45","author":"Lippa","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0925","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1212\/01.wnl.0000230161.28299.3c","article-title":"Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer's disease","volume":"67","author":"L\u00f3pez","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb0930","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ana.22363","article-title":"Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy","volume":"70","author":"L\u00f3pez-Erauskin","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0935","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1196\/annals.1344.031","article-title":"Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin\u2013proteasome subunits, SKP1A, aldehyde dehydrogennase, and chaperone HSC-70","volume":"1053","author":"Mandel","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb0940","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/mds.22990","article-title":"Complex paroxysmal nocturnal behaviors in Parkinson's disease","volume":"25","author":"Manni","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb0945","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1212\/WNL.0b013e318198df97","article-title":"Can we image premotor Parkinson disease?","volume":"72","author":"Marek","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb0950","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/NEN.0b013e3181ac10a7","article-title":"Lewy body pathology in normal elderly subjects","volume":"68","author":"Markesbery","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0955","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/brain\/awn309","article-title":"Temporal dynamics of basal ganglia under-recruitment in Parkinson's disease: transient caudate abnormalities during updating of working memory","volume":"132","author":"Marklund","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb0960","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00415-009-5328-7","article-title":"REM sleep behaviour disorder and visuoperceptive dysfunction: a disorder of the ventral visual stream?","volume":"257","author":"Marques","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0965","first-page":"285","article-title":"Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease","volume":"100","author":"Martilla","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0970","doi-asserted-by":"crossref","first-page":"52984","DOI":"10.1074\/jbc.M409028200","article-title":"\u03b1-Synuclein expression levels do not significantly affect proteasome function and expression in mice and stably transfected PC12 cell lines","volume":"279","author":"Mart\u00ecn-Clemente","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.10.019_bb0975","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1750-3639.2009.00326.x","article-title":"Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates","volume":"20","author":"Mart\u00ednez","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0980","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-510X(02)00006-0","article-title":"Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies","volume":"195","author":"Marui","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb0985","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneurol.2007.68","article-title":"Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders","volume":"65","author":"Mata","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb0990","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1176\/ajp.143.6.756","article-title":"Clinical and biochemical features of depression in Parkinson's disease","volume":"143","author":"Mayeux","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2011.10.019_bb0995","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson's disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb1875","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","article-title":"International Psychogeriatric Association Expert Meeting on DLB. Dementia with Lewy bodies","volume":"3","author":"McKeith","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000235247","article-title":"Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease","volume":"28","author":"McKinlay","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb1015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.10.019_bb1020","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1046\/j.1460-9568.2002.02301.x","article-title":"Aggresome-related biogenesis of Lewy bodies","volume":"16","author":"McNaught","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.10.019_bb1010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","article-title":"Altered proteasomal function in sporadic Parkinson's disease","volume":"179","author":"McNaught","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1025","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1586\/erm.10.86","article-title":"Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities","volume":"10","author":"Mellick","year":"2010","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"Suppl 1","key":"10.1016\/j.nbd.2011.10.019_bb1035","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1007\/s100720300035","article-title":"Autonomic dysfunction in Parkinson's disease","volume":"24","author":"Micieli","year":"2003","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb1040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nbd.2005.07.010","article-title":"Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease","volume":"21","author":"Miller","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.10.019_bb1030","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1212\/01.wnl.0000264429.59379.d9","article-title":"Do \u03b1-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study","volume":"68","author":"M\u00ednguez-Castellanos","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb1050","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","article-title":"Early downregulation of miR-34b and miR-34c in brain may contribute to mitochondrial dysfunction in Parkinson's disease","volume":"20","author":"Mi\u00f1ones-Moyano","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.10.019_bb1045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2005.11.034","article-title":"Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson's disease","volume":"243","author":"Mitsui","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb1055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/brain\/awl326","article-title":"Cortical activity in Parkinson's disease during executive processing depends on striatal involvement","volume":"130","author":"Monchi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb1060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2007.09.004","article-title":"Extrastriatal monoaminergic neuron function in Parkinson's disease: an 18F-dopa PET study","volume":"29","author":"Moore","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.10.019_bb1065","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2217\/bmm.10.95","article-title":"Olfaction as a biomarker in Parkinson's dsease","volume":"4","author":"Morley","year":"2010","journal-title":"Biomark. Med."},{"key":"10.1016\/j.nbd.2011.10.019_bb1070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/mds.23387","article-title":"Parwest Study group. Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: frequent but mild","volume":"26","author":"M\u00fcller","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb1075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1471-4159.2011.07175.x","article-title":"DJ-1 deficiency in astrocytes selectively enhances mitochondrial Complex I inhibitor-induced neurotoxicity","volume":"117","author":"Mullett","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.10.019_bb1880","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00401-011-0830-2","article-title":"Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders","volume":"122","author":"Mundia\u00f1o","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1085","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuroscience.2008.01.030","article-title":"Phosphorylation of tau and \u03b1-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related \u03b1-synucleinopathies","volume":"152","author":"Muntan\u00e9","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.10.019_bb1090","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2982.2008.01162.x","article-title":"Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation","volume":"20","author":"Natale","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.nbd.2011.10.019_bb1885","series-title":"Lipid Peroxidation: Biological Implications","first-page":"47","article-title":"Membrane unsaturation, selective neuronal vulnerablity, and age-related neurodegenerative diseases","author":"Naudi","year":"2011"},{"key":"10.1016\/j.nbd.2011.10.019_bb1100","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10863-009-9250-6","article-title":"Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease","volume":"41","author":"Navarro","year":"2009","journal-title":"J. Bioenerg. Biommebr."},{"key":"10.1016\/j.nbd.2011.10.019_bb1105","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.freeradbiomed.2009.03.007","article-title":"Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies","volume":"46","author":"Navarro","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2011.10.019_bb1110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of \u03b1-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.10.019_bb1115","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.20753","article-title":"Clinical heterogeneity of \u03b1-synuclein gene duplication in Parkinson's disease","volume":"59","author":"Nishioka","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1120","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/brain\/awn102","article-title":"Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation","volume":"131","author":"Nolano","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb1890","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0002-9440(10)65722-7","article-title":"Lewy bodies contain altered \u03b1-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes","volume":"153","author":"O'Connell","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.archger.2010.02.005","article-title":"Autonomic and cognitive functions in Parkinson's disease","volume":"52","author":"Oh","year":"2011","journal-title":"Arch. Neurol. Geriatr."},{"key":"10.1016\/j.nbd.2011.10.019_bb1135","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00401-009-0629-6","article-title":"\u03b1-Synuclein pathology in the spinal cord autonomic nuclei associates with \u03b1-synuclein pathology in the brain: a population-based Vantaa 85+ study","volume":"119","author":"Oinas","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2007.01.002","article-title":"Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson's disease","volume":"254","author":"Oka","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb1140","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.4161\/cc.8.18.9512","article-title":"Dopaminergic modulation of neurogenesis in the subventricular zone of the adult brain","volume":"8","author":"O'Keeffe","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.nbd.2011.10.019_bb1895","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.nbd.2011.05.025","article-title":"Familial Parkinson disease mutations influence synuclein assembly","volume":"43","author":"Ono","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.10.019_bb1155","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-005-0995-7","article-title":"Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease","volume":"109","author":"Orimo","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1750-3639.2006.00032.x","article-title":"Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease","volume":"17","author":"Orimo","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1165","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awm302","article-title":"Axonal \u03b1-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease","volume":"131","author":"Orimo","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb1170","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/brain\/121.5.949","article-title":"Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions","volume":"121","author":"Owen","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb1900","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Paisanz-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.10.019_bb1180","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1074\/jbc.M401135200","article-title":"Mitochondrial dysfunction and oxidative damage in parkin-deficient mice","volume":"279","author":"Palacino","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.10.019_bb1185","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1074\/mcp.M700158-MCP200","article-title":"Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer","volume":"6","author":"Pan","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.nbd.2011.10.019_bb1190","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00415-005-0918-5","article-title":"Psychotic symptoms in Parkinson's disease. From description to etiology","volume":"252","author":"Papapetropoulos","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1195","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.parkreldis.2005.10.005","article-title":"Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations","volume":"12","author":"Papapetropoulos","year":"2006","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb1200","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","article-title":"Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin","volume":"441","author":"Park","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.10.019_bb1210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00401-008-0346-6","article-title":"Applicability of current staging\/categorization of \u03b1-synuclein pathology and their clinical relevance","volume":"115","author":"Parkkinen","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1220","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jnen\/62.4.363","article-title":"Regional distribution of \u03b1-synuclein pathology in unimpaired aging and Alzheimer disease","volume":"62","author":"Parkkinen","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1205","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.20321","article-title":"\u03b1-Synuclein pathology does not predict extrapyramidal symptoms or dementia","volume":"57","author":"Parkkinen","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1215","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1440-1789.2005.00644.x","article-title":"Widespread and abundant \u03b1-synuclein pathology in a neurologically unimpaired subject","volume":"25","author":"Parkkinen","year":"2005","journal-title":"Neuropathology"},{"key":"10.1016\/j.nbd.2011.10.019_bb1225","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/brain\/awq268","article-title":"Fatigiue in Parkinson's disease is linked to striatal and limbic serotoninergic dysfunction","volume":"133","author":"Pavese","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb1230","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mds.870100309","article-title":"The anterior olfactory nucleus in Parkinson's disease","volume":"10","author":"Pearce","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb1235","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/jnnp.2008.170043","article-title":"Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study","volume":"80","author":"Pedersen","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2011.10.019_bb1240","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1471-4159.2005.03442.x","article-title":"Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function","volume":"95","author":"Periquet","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.10.019_bb1245","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1749-6632.1991.tb00217.x","article-title":"Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease","volume":"640","author":"Perry","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb1250","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1586\/epr.10.8","article-title":"Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis","volume":"7","author":"Pienaar","year":"2010","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.nbd.2011.10.019_bb1260","doi-asserted-by":"crossref","first-page":"S374","DOI":"10.1002\/mds.21681","article-title":"Dysautonomia and cognitive dysfunction in Parkinson's disease","volume":"17","author":"Poewe","year":"2007","journal-title":"Mov. Disord. Suppl."},{"issue":"Suppl 1","key":"10.1016\/j.nbd.2011.10.019_bb1265","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson's disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1270","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/WNL.0b013e3181feb2ab","article-title":"Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures","volume":"75","author":"Politis","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb1275","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.10.019_bb1280","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1073\/pnas.0709336105","article-title":"The PINK1\/parkin pathway regulates mitochondrial morphology","volume":"105","author":"Poole","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.10.019_bb1285","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nbd.2004.12.009","article-title":"Mitochondrial associated metabolic proteins are selectively oxidized in A30P \u03b1-synuclein transgenic mice \u2014 a model of familial Parkinson's disease","volume":"18","author":"Poon","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.10.019_bb1290","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/archneur.61.12.1915","article-title":"Lewy bodies in the amygdala: increase of \u03b1-synuclein aggregates in neurodegenerative diseases with tau-based inclusions","volume":"61","author":"Popescu","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1295","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1212\/01.wnl.0000203648.80727.5b","article-title":"Potential early markers of Parkinson disease in idiopathic REM sleep behavioral disorder","volume":"66","author":"Postuma","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb1300","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00401-008-0438-3","article-title":"Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies","volume":"117","author":"Power","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1255","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2010.04.022","article-title":"Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease","volume":"477","author":"Prigione","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"Suppl 1","key":"10.1016\/j.nbd.2011.10.019_bb1305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2008.02057.x","article-title":"New insights into the pathology of Parkinson's disease: does the peripheral autonomic system become central?","author":"Probst","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1310","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nurt.2010.07.001","article-title":"Astrocytes and therapeutics for Parkinson's disease","volume":"7","author":"Rappold","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2011.10.019_bb1315","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb1320","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/j.1582-4934.2008.00450.x","article-title":"Immunological features of alpha-synuclein in Parkinson's disease","volume":"12","author":"Roodveldt","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.nbd.2011.10.019_bb1325","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/mds.23179","article-title":"Midbrain SERT in degenerative parkinsonisms: a 123I-FP-CIT SPECT study","volume":"25","author":"Roselli","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb1330","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.21291","article-title":"Association of olfactory dysfunction with risk for future Parkinson's disease","volume":"63","author":"Ross","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1335","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10863-009-9259-x","article-title":"Mitochondrial matters in Parkinson disease: introduction","volume":"41","author":"Sack","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.nbd.2011.10.019_bb1350","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","article-title":"A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death","volume":"137","author":"Saijo","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.10.019_bb1345","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnen\/63.7.742","article-title":"Lewy body-related \u03b1-synucleinopathy in aging","volume":"63","author":"Saito","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1355","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awq051","article-title":"PINK1-linked parkinsonism is associated with Lewy body pathology","volume":"133","author":"Samaranch","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb1360","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.neuropharm.2010.11.024","article-title":"Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy","volume":"60","author":"S\u00e1nchez","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2011.10.019_bb1365","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archneur.1996.00550120077019","article-title":"Visual hallucinations associated with Parkinson disease","volume":"53","author":"Sanchez-Ramos","year":"1966","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1370","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00401-008-0478-8","article-title":"LRRK2 and neurodegeneration","volume":"117","author":"Santpere","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1375","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1331.2008.02372.x","article-title":"Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease","volume":"16","author":"Sawada","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1380","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/brain\/awn054","article-title":"Cognitive deficits and striato-frontal dopamine release in Parkinson's disease","volume":"131","author":"Sawamoto","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb1385","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson's disease","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1905","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22245","article-title":"White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study","volume":"69","author":"Scherfler","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1395","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/hmg\/ddq564","article-title":"Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria","volume":"20","author":"Schmidt","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.10.019_bb1400","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","article-title":"Lewy bodies","volume":"103","author":"Schults","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.10.019_bb1405","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of \u03b1-synuclein in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1410","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/NEN.0b013e31818b4126","article-title":"Incidence and extent of Lewy body-related \u03b1-synucleinopathy in aging human olfactory bulb","volume":"67","author":"Sengoku","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1910","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2011.06.047","article-title":"Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease","author":"Sharabi","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb1425","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/nen.0b013e318163354a","article-title":"Mortalin: a protein associated with progression of Parkinson disaese?","volume":"67","author":"Shi","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1420","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2353\/ajpath.2009.081019","article-title":"Glutathion S-transferase pi as a protein involved in Parkinson disease progression","volume":"175","author":"Shi","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1430","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","article-title":"Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET","volume":"73","author":"Shimada","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb1435","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11910-006-0021-z","article-title":"Preclinical diagnosis of Parkinson's disease: are we there yet?","volume":"6","author":"Siderowf","year":"2006","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.nbd.2011.10.019_bb1440","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2011.10.019_bb1445","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2009.02.006","article-title":"Regional differences in the severity of Lewy body pathology across the olfactory cortex","volume":"453","author":"Silveira-Moriyama","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.10.019_bb1450","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/hmg\/ddi377","article-title":"Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism","volume":"14","author":"Silvestri","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.10.019_bb1455","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/brain\/awn323","article-title":"Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathogenesis","volume":"132","author":"Simunovic","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb1460","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"\u03b1-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.10.019_bb1465","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10863-009-9254-2","article-title":"Mitochondrial dysfunction in mouse models of Parkinson's disease revealed by transcriptomics and proteomics","volume":"41","author":"Smith","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.nbd.2011.10.019_bb1470","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.0508052102","article-title":"Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin and mutant LRRK2 induces neuronal degeneration","volume":"102","author":"Smith","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.10.019_bb1915","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2011.07.047","article-title":"Initial neuropsychological impairments in patients with the E46K mutation of the \u03b1-synuclein gene (PARK 1)","author":"Somme","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb1485","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.10.019_bb1480","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1073\/pnas.95.11.6469","article-title":"\u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.10.019_bb9005","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/mds.22184","article-title":"Neuronal gene expression correlates of Parkinson's disease with dementia","volume":"23","author":"Stamper","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb1490","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/brain\/awh322","article-title":"Combination of idiopathic REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT","volume":"128","author":"Stiasny-Kolster","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb1495","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/hmg\/ddi215","article-title":"Loss of function mutations in the gene encoding Omi\/HtrA2 in Parkinson's disease","volume":"14","author":"Strauss","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.10.019_bb1920","first-page":"71","article-title":"Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG","volume":"41","author":"Takatsu","year":"2000","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nbd.2011.10.019_bb1510","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF00369454","article-title":"Parkinson's disease with involvement of the parasympathetic ganglia","volume":"86","author":"Takeda","year":"1993","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1515","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1523\/JNEUROSCI.4188-09.2010","article-title":"Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease","volume":"30","author":"Tang","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.10.019_bb1925","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00401-010-0676-z","article-title":"Proteinase K-resistant \u03b1-synuclein is deposited in presynapses in human Lewy body disease and A53T synuclein transgenic mice","volume":"120","author":"Tanji","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1930","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00401-006-0192-3","article-title":"Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer's disease","volume":"113","author":"Terni","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1935","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3174\/ajnr.A0900","article-title":"A whole-brain analysis in de novo Parkinson disease","volume":"29","author":"Tessa","year":"2008","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1535","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/brain\/awm097","article-title":"Hypocretin (orexin) cell loss in Parkinson's disease","volume":"130","author":"Thannickal","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.10.019_bb1540","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1093\/hmg\/ddm159","article-title":"Parkinson's disease","volume":"16","author":"Thomas","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.10.019_bb1940","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10286-010-0068-4","article-title":"Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation in the \u03b1-synuclein gene (SNCA)","volume":"20","author":"Tijero","year":"2010","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.nbd.2011.10.019_bb1550","doi-asserted-by":"crossref","first-page":"44405","DOI":"10.1074\/jbc.M308041200","article-title":"Ubiquitination of synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function","volume":"278","author":"Tofaris","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.10.019_bb1555","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.parkreldis.2007.06.007","article-title":"The premotor phase of Parkinson's disease","volume":"13","author":"Tolosa","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb9010","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1074\/mcp.M400117-MCP200","article-title":"\"Subcellular proteomics\" of neuromelanin granules isolated from the human brain","volume":"4","author":"Tribl","year":"2005","journal-title":"Mol. Cell. Proteomics."},{"key":"10.1016\/j.nbd.2011.10.019_bb1560","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00401-010-0687-9","article-title":"\u03b1-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells","volume":"119","author":"Ubeda-Ba\u00f1on","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1565","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","article-title":"Alzheimer disease with amygdala Lewy bodies: a distinct form of \u03b1-synucleinopathy","volume":"65","author":"Uchikado","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1570","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jnr.21130","article-title":"Oxidative stress in the aging murine olfactory bulb: redox proteomics and cellular localization","volume":"85","author":"Vaishnav","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.10.019_bb1575","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/mds.23348","article-title":"Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease","volume":"25","author":"Valappil","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb1580","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.10.019_bb1625","doi-asserted-by":"crossref","first-page":"42655","DOI":"10.1074\/jbc.M505910200","article-title":"Similar patterns of mitochondrial vulnerability and rescue induced by genetic modifications of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans","volume":"280","author":"Ved","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.10.019_bb1585","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/B978-0-444-52007-4.00019-9","article-title":"Sleep disorders in Parkinson's disease","volume":"99","author":"Videnovic","year":"2011","journal-title":"Handb. Clin. Neurol."},{"issue":"Suppl 2","key":"10.1016\/j.nbd.2011.10.019_bb1595","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000113469","article-title":"Neuropathology of autonomic nervous system in Parkinson's disease","volume":"38","author":"Wakabayashi","year":"1997","journal-title":"Eur. Neurol."},{"issue":"249","key":"10.1016\/j.nbd.2011.10.019_bb1945","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","article-title":"NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease","volume":"1197","author":"Wakabayashi","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.10.019_bb1600","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00294234","article-title":"Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system","volume":"79","author":"Wakabayashi","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1605","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","article-title":"Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses","volume":"76","author":"Wakabayashi","year":"1998","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1610","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","article-title":"The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of \u03b1-synuclein aggregates","volume":"27","author":"Wakabayashi","year":"2007","journal-title":"Neuropathology"},{"key":"10.1016\/j.nbd.2011.10.019_bb1615","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0404.2007.00887.x","article-title":"Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson's disease \u2014 a rCBF scintigraphic study","volume":"116","author":"Wallin","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2011.10.019_bb1620","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajhg.2007.09.021","article-title":"Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein","volume":"82","author":"Wang","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2011.10.019_bb1630","doi-asserted-by":"crossref","first-page":"15410","DOI":"10.1523\/JNEUROSCI.1909-09.2009","article-title":"Olfactory impairment predicts brain atrophy in Parkinson's disease","volume":"29","author":"Wattendorf","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.10.019_bb1635","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1212\/01.wnl.0000266626.64913.0f","article-title":"In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution","volume":"69","author":"Weisman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.10.019_bb1950","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-5956-6-8","article-title":"Proteome analysis of human substantia nigra in Parkinson's disease","volume":"6","author":"Werner","year":"2008","journal-title":"Proteome Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb1645","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/jnnp.2006.113860","article-title":"Functional imaging of the cerebral olfactory system in patients with Parkinson's disease","volume":"79","author":"Westermann","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2011.10.019_bb1655","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbadis.2009.08.013","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"1802","author":"Winklhofer","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2011.10.019_bb1650","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1097\/00001756-200011270-00029","article-title":"Lewy body variant of Alzheimer's disease: \u03b1-synuclein in dystrophic neurites of A beta plaques","volume":"11","author":"Wirths","year":"2000","journal-title":"Neuroreport"},{"issue":"Supl 3","key":"10.1016\/j.nbd.2011.10.019_bb1955","doi-asserted-by":"crossref","first-page":"III\/22","DOI":"10.1007\/PL00007822","article-title":"Intrinsic and extrinsic psychosis in Parkinson's disease","volume":"248","author":"Wolters","year":"2001","journal-title":"J. Neurol."},{"issue":"Suppl 70","key":"10.1016\/j.nbd.2011.10.019_bb1960","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-3-211-45295-0_47","article-title":"Parkinson's disease: pre-motor clinico-pathological correlations","author":"Wolters","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.10.019_bb1670","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.2741\/2973","article-title":"Proteomic identification of novel proteins associated with Lewy bodies","volume":"13","author":"Xia","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.nbd.2011.10.019_bb1680","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/pr060488o","article-title":"Protein expression in a Drosophila model of Parkinson's disease","volume":"6","author":"Xun","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.nbd.2011.10.019_bb1685","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1074\/mcp.M700467-MCP200","article-title":"Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease","volume":"7","author":"Xun","year":"2008","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.nbd.2011.10.019_bb1675","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1021\/pr9006238","article-title":"Stable isotope labeling and label-free proteomics of Drosophila parkin null mutants","volume":"8","author":"Xun","year":"2009","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.nbd.2011.10.019_bb1690","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nbd.2007.11.008","article-title":"Transcriptional dysregulation in a transgenic model of Parkinson's disease","volume":"29","author":"Yacoubian","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.10.019_bb1695","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2007.01.029","article-title":"Correlation in Lewy pathology between the claustrum and visual areas in brains of dementia with Lewy bodies","volume":"415","author":"Yamamoto","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.10.019_bb1700","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/jnen\/59.7.585","article-title":"\u03b1-Synuclein inclusions in amygdala in the brains of patients with the parkinsonism\u2013dementia complex of Guam","volume":"59","author":"Yamazaki","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1705","doi-asserted-by":"crossref","first-page":"13670","DOI":"10.1073\/pnas.0504610102","article-title":"Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase\/Akt signaling","volume":"102","author":"Yang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.10.019_bb1715","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1440-1789.2006.00736.x","article-title":"Lewy body variant of Alzheimer's disease or cerebral type Lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem","volume":"27","author":"Yokota","year":"2007","journal-title":"Neuropathology"},{"key":"10.1016\/j.nbd.2011.10.019_bb1710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10072-010-0424-0","article-title":"Role of glial cells in neurotoxin-induced animal models of Parkinson's disease","volume":"32","author":"Yokoyama","year":"2011","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.10.019_bb1720","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1468-1331.2007.01977.x","article-title":"A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies","volume":"14","author":"Yong","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1965","first-page":"473640","article-title":"Non-motor symptoms in patients with PARK2 mutations","author":"Yoritaka","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.nbd.2011.10.019_bb9015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.neuroscience.2004.09.054","article-title":"The amygdala of patients with Parkinson's disease is silent in response to fearful facial expressions","volume":"131","author":"Yoshimura","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.10.019_bb1735","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus ceruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1740","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of \u03b1-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.10.019_bb1730","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.30195","article-title":"Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms","volume":"137","author":"Zhang","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.nbd.2011.10.019_bb1745","doi-asserted-by":"crossref","first-page":"39155","DOI":"10.1074\/jbc.M405456200","article-title":"Analysis of synuclein-associated proteins by quantitative proteomics","volume":"279","author":"Zhou","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.10.019_bb1750","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.parkreldis.2006.12.014","article-title":"Non-motor dysfunction in Parkinson's disease","volume":"13","author":"Ziemssen","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.10.019_bb1755","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111003512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111003512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T01:38:46Z","timestamp":1639359526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996111003512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":352,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0969996111003512"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2011.10.019","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}